Healthcare News: FDA issues EUA for new COVID-19 antibody treatment
February 23rd, 2021
The Food and Drug Administration (FDA) recently issued an emergency use authorization (EUA) for the combination treatment of bamlanivimab and etesevimab for COVID-19 patients at high risk for severe infection.
To read the full article, sign in and subscribe to the JustCoding Newsletters.
Access to this feature is available in the following products:
HCPro's JustCoding Newsletters +Archives
The JustCoding® Newsletter is a fantastic resource for coding professionals. Whether you're an inpatient or outpatient coder, a veteran or new to the job, JustCoding will keep your skills sharp and help you stay abreast of CMS changes.